Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desoximetasone Spray in Plaque Psoriasis
NCT01018134Phase 2Completed
- Start
- Nov 2009
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of desoximetasone in plaque psoriasis (6 arms). Primary endpoints: Number of Participants in Each Treatment Group With Clinical Cure (PGA Score = 0 or 1) at 28 days and Number of Participants in Each Treatment Group With Treatment Success for the Target Lesion at 28 days. Started Nov 2009; status: completed.
02
Drugs
desoximetasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01018134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018134.